As of Jun 29
| -0.115 / -2.18%|
The 3 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 16.00. The median estimate represents a +267.86% increase from the last price of 5.17.
The current consensus among 3 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.